Strain Information | |
|---|---|
| Image | ![]() |
| BRC No. | RBRC02285 |
| Type | Targeted Mutation and Transgene |
| Species | Mus musculus |
| Strain name | C57BL/6-St3gal4<tm1.1Bsi> |
| Former Common name | ST34(#9 CAGCre)C57BL/6J:913 line, 913; C57BL/6-St3gal4<tm1.1Bsi> Tg(CAG-cre)913Bsi |
| H-2 Haplotype | |
| ES Cell line | MS12 [C57BL/6] |
| Background strain | C57BL/6JJcl |
| Appearance | black [a/a B/B C/C] |
| Strain development | 2004年、平林義雄先生、RIKEN BSI |
| Strain description | ST3GAL IV conditional targeted mouseの受精卵にCAG-Cre plasmidをtransfectしたもので、ST34GAL IV遺伝子の全身KOマウス。 |
| Colony maintenance | 繁殖効率C行動の異常がある繁殖成績が低いホモで不妊/死亡 |
| References | |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| St3gal4 MGI:1316743 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | 9 | St3gal4<tm1.1Bsi> | targeted mutation 1.1, RIKEN BSI | |||
| loxP | phage P1 loxP | 9 | loxP | ||||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | more 5 phenotypes |
| Detailed phenotype data | |
Ordering Information | |
|---|---|
| 供与核酸 | mouse ST3Gal IV genomic DNA, phage P1 loxP, CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
| Research application | Metabolism Research Mouse Models for Human Disease |
| 提供条件 | 条件を付加しない。 |
| Depositor | 平林 義雄(独立行政法人理化学研究所) |
| Strain Status | 凍結胚 |
| Strain Availability | 凍結胚より作出したマウスを2~4ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 |
| Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
|---|
Fujita A, Okuno T, Oda M, Kato K. Urinary volatilome analysis in a mouse model of anxiety and depression. PLoS One 15(2) e0229269(2020) 32084196 |
Kato K. Differential effects of dietary oils on emotional and cognitive behaviors. PLoS One 10(3) e0120753(2015) 25799588 |
Srimontri P, Endo S, Sakamoto T, Nakayama Y, Kurosaka A, Itohara S, Hirabayashi Y, Kato K. Sialyltransferase ST3Gal IV deletion protects against temporal lobe epilepsy. J Neurochem 131(5) 675-87(2014) 25066807 |